Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for “Sycamore Mid Cap Value Equity Strategy”. A copy of the letter can be downloaded here. Sycamore Capital’s Mid Cap Value investment team focuses on a bottom-up approach to identify undervalued businesses with growth potential. In Q2 2026, the strategy returned 9.6% (net) underperforming the Russell Midcap Value Index’s 13.83% return, due to both stock selection and sector allocation. Small-cap equities outpaced both large- and mid-cap equities during the second quarter of 2026. While U.S. indices like the S&P 500® Index saw significant gains in the quarter, market dynamics shifted towards a select group of stocks driven by AI-related momentum. The commentary highlights underlying risks, such as market concentration and the influence of passive investment vehicles, reminding investors to reconsider their exposure to AI. Overall, it calls for a cautious evaluation of current investments in light of these risks. Please review the Fund’s top five holdings to gain insights into their key selections for 2026.
In its Q2 2026 investor letter, Sycamore Mid Cap Value Equity Strategy highlighted Molina Healthcare, Inc. (NYSE:MOH). Molina Healthcare, Inc. (NYSE:MOH), a managed healthcare services company that operates through Medicaid, Medicare, Marketplace, and other segments, contributed to the strategy’s performance this quarter. On August 12, 2026, Molina Healthcare, Inc. (NYSE:MOH) closed at $206.06 per share, reflecting a market capitalization of $10.76 billion and a year‑to‑date gain of 20.40%. Molina Healthcare, Inc. (NYSE:MOH) posted a one‑month return of ‑7.06%, while its shares gained 30.90% over the past 52 weeks.”
Sycamore Mid Cap Value Equity Strategy stated the following regarding Molina Healthcare, Inc. (NYSE:MOH) in its Q2 2026 investor letter:
“Molina Healthcare, Inc. (NYSE:MOH), a U.S. managed care organization focused on government-sponsored health plans (Medicaid, Medicare, and Marketplace), was the quarter’s top contributor. Shares rallied after a strong 1Q26 earnings report refocused investor attention on MOH’s core government-sponsored plan business. After a challenging 2025, including a significant 3Q EPS miss, the results signaled that the worst of the medical cost ratio (MCR) deterioration was likely behind the company. Shares also benefitted as investors gained greater visibility into the timing and scale of Medicaid spending cuts under the “One Big Beautiful Bill Act.” Late in the quarter, shares got another lift when CMS released 2025 risk-adjustment transfer data that was viewed favorably for managed care companies. Our thesis for MOH remains intact.”
Molina Healthcare, Inc. (NYSE:MOH) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 51 hedge fund portfolios held Molina Healthcare, Inc. (NYSE:MOH) at the end of the first quarter, compared to 55 in the previous quarter. While we acknowledge the risk and potential of Molina Healthcare, Inc. (NYSE:MOH) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Molina Healthcare, Inc. (NYSE:MOH) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Molina Healthcare, Inc. (NYSE:MOH) and shared a list of best turnaround stocks to buy in 2026. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
